Epidemiological studies in adults have shown an association between IGF-1 levels in the upper quartile of the normal range and an increased risk of colorectal cancer, breast cancer, and prostate cancer, while IGF-1 levels in the lower quartile of the normal range have been linked to ischemic heart disease (11, 12). Here, IGF1 is linked to prostate carcinoma.